Wang Jie-Mei, Huang Yi-Jun, Wang Yan, Xu Ming-Guo, Wang Li-Chung, Wang Shen-Ming, Tao Jun
Department of Cardiology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Am J Hypertens. 2007 Sep;20(9):957-64. doi: 10.1016/j.amjhyper.2007.04.005.
Impaired artery elasticity has been found in various pathological conditions related to endothelial dysfunction. Recently, CD31+/CD42- microparticles (MPs) emerged as a marker of endothelial injury. Whether CD31+/CD42- MPs, generated under physiological conditions, are correlated with artery properties has not been reported.
We evaluated brachia-ankle pulse-wave velocity (baPWV) (n = 76) and C1 large-artery and C2 small-artery elasticity indices (n = 56), using noninvasive devices for pulse-wave analysis in a group of healthy persons. The number of circulating CD31+/CD427- MPs (n = 76) was measured by flow cytometric analysis.
Circulating CD31+/CD42- MPs were positively correlated with values of baPWV (r = 0.371, P = .008) and with C1 large-artery and C2 small-artery elasticity indices (r = -0.294, P = .037; and r = -0.310, P = .027, respectively). Multivariate analysis identified CD31+/CD42- MPs as potent contributors to the development of impaired systemic artery elasticity.
The level of circulating CD31+/CD42- MPs, an important biomarker of dysfunctional endothelium and vascular injury, is closely associated with impaired systemic artery elasticity in healthy subjects. The present study suggests that CD31+/CD42- MPs may be a novel surrogate marker for the clinical evaluation of vascular damage.
在各种与内皮功能障碍相关的病理状况中均发现动脉弹性受损。最近,CD31+/CD42-微粒(MPs)成为内皮损伤的标志物。生理条件下产生的CD31+/CD42- MPs是否与动脉特性相关尚未见报道。
我们使用无创脉搏波分析设备,对一组健康人评估了肱踝脉搏波速度(baPWV)(n = 76)以及C1大动脉和C2小动脉弹性指数(n = 56)。通过流式细胞术分析测定循环CD31+/CD427- MPs的数量(n = 76)。
循环CD31+/CD42- MPs与baPWV值呈正相关(r = 0.371,P = 0.008),与C1大动脉和C2小动脉弹性指数也呈正相关(分别为r = -0.294,P = 0.037;以及r = -0.310,P = 0.027)。多变量分析确定CD31+/CD42- MPs是全身动脉弹性受损发展的有力促成因素。
循环CD31+/CD42- MPs水平是功能失调内皮和血管损伤的重要生物标志物,与健康受试者全身动脉弹性受损密切相关。本研究表明,CD31+/CD42- MPs可能是用于血管损伤临床评估的新型替代标志物。